Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Owen

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
British Journal of Clinical Pharmacology|November 28, 2022
The effect of TRV027 on coagulation in COVID-19: A pilot randomized, placebo-controlled trialAlexander J Robbins, Nur Amalina Che Bakri, Edward Toke-Bjolgerud, et al.
Journal of Chemical Information and Modeling|April 14, 2023
AI-Driven Discovery of SARS-CoV-2 Main Protease Fragment-like Inhibitors with Antiviral Activity <i>In Vitro</i>Luiz Carlos Saramago, Marcos V Santana, Bárbara Figueira Gomes, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
ProCyon: A multimodal foundation model for protein phenotypesOwen Queen, Yepeng Huang, Robert Calef, et al.
Chemical Science|November 11, 2021
Discovery of SARS-CoV-2 M<sup>pro</sup> peptide inhibitors from modelling substrate and ligand bindingH T Henry Chan, Marc A Moesser, Rebecca K Walters, et al.
Eclinicalmedicine|January 19, 2022
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trialKatrina M Pollock, Hannah M Cheeseman, Alexander J Szubert, et al.
Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Brain : a Journal of Neurology|August 15, 2018
SYT1-associated neurodevelopmental disorder: a case seriesKate Baker, Sarah L Gordon, Holly Melland, et al.
Scientific Reports|September 29, 2021
Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Communications Chemistry|October 12, 2023
Experimental phasing opportunities for macromolecular crystallography at very long wavelengthsKamel El Omari, Ramona Duman, Vitaliy Mykhaylyk, et al.
Nature Communications|October 8, 2020
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main proteaseAlice Douangamath, Daren Fearon, Paul Gehrtz, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
British Journal of Clinical Pharmacology|November 28, 2022
The effect of TRV027 on coagulation in COVID-19: A pilot randomized, placebo-controlled trialAlexander J Robbins, Nur Amalina Che Bakri, Edward Toke-Bjolgerud, et al.
Journal of Chemical Information and Modeling|April 14, 2023
AI-Driven Discovery of SARS-CoV-2 Main Protease Fragment-like Inhibitors with Antiviral Activity <i>In Vitro</i>Luiz Carlos Saramago, Marcos V Santana, Bárbara Figueira Gomes, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
ProCyon: A multimodal foundation model for protein phenotypesOwen Queen, Yepeng Huang, Robert Calef, et al.
Chemical Science|November 11, 2021
Discovery of SARS-CoV-2 M<sup>pro</sup> peptide inhibitors from modelling substrate and ligand bindingH T Henry Chan, Marc A Moesser, Rebecca K Walters, et al.
Eclinicalmedicine|January 19, 2022
Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trialKatrina M Pollock, Hannah M Cheeseman, Alexander J Szubert, et al.
Scientific Reports|June 25, 2021
Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Brain : a Journal of Neurology|August 15, 2018
SYT1-associated neurodevelopmental disorder: a case seriesKate Baker, Sarah L Gordon, Holly Melland, et al.
Scientific Reports|September 29, 2021
Publisher Correction: Bispecific repurposed medicines targeting the viral and immunological arms of COVID-19Martin A Redhead, C David Owen, Lennart Brewitz, et al.
Communications Chemistry|October 12, 2023
Experimental phasing opportunities for macromolecular crystallography at very long wavelengthsKamel El Omari, Ramona Duman, Vitaliy Mykhaylyk, et al.
Nature Communications|October 8, 2020
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main proteaseAlice Douangamath, Daren Fearon, Paul Gehrtz, et al.
Pageof 17